{"_links": {"parentPackage": {"href": "/mdr/ct/packages/protocolct-2023-06-30", "title": "Protocol Controlled Terminology Package 54 Effective 2023-06-30", "type": "Terminology"}, "rootItem": {"href": "/mdr/root/ct/protocolct/codelists/C199649", "title": "Version-agnostic anchor resource for codelist C199649", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/protocolct-2023-06-30/codelists/C199649", "title": "CDISC Protocol Pharmacology Attribute Terminology", "type": "Code List"}}, "conceptId": "C199649", "definition": "A terminology value set relevant to the attributes of the pharmacology entity.", "name": "Pharmacology Attribute Terminology", "preferredTerm": "CDISC Protocol Pharmacology Attribute Terminology", "submissionValue": "Pharmacology Attribute Terminology", "synonyms": ["Pharmacology Attribute Terminology"], "terms": [{"conceptId": "C64774", "definition": "The area between the x-axis and the curve given by the integrand, equal to the definite integral of a function. For the purpose of pharmacokinetic measurements, the area under the curve (AUC) is the area under the curve in a plot of concentration of a drug in tissue, blood, or other body fluid against time.", "preferredTerm": "Area Under Curve", "submissionValue": "Area Under the Curve", "synonyms": ["AUC"]}, {"conceptId": "C16975", "definition": "The study of assessing therapeutic value of a drug in humans, including properties (absorption, distribution, metabolism, and excretion (ADME)), effects, reactions, and uses.", "preferredTerm": "Clinical Pharmacology", "submissionValue": "Clinical Pharmacology"}, {"conceptId": "C79369", "definition": "The branch of pharmacokinetics that studies the process by which a drug is absorbed by the body.", "preferredTerm": "Pharmacokinetics: Absorption", "submissionValue": "Drug Absorption", "synonyms": ["Absorption", "FDA RPS Pharmacokinetics: Absorption"]}, {"conceptId": "C199691", "definition": "The strength of the binding interaction between a drug and its target(s).", "preferredTerm": "Drug Binding Affinity", "submissionValue": "Drug Binding Affinity"}, {"conceptId": "C70913", "definition": "The rate and extent to which the active drug ingredient or therapeutic moiety is absorbed from a drug product and becomes available at the site of drug action. (US FDA 21 CFR 320.1)", "preferredTerm": "Bioavailability", "submissionValue": "Drug Bioavailability", "synonyms": ["Bioavailability"]}, {"conceptId": "C199688", "definition": "The rate at which a drug is removed or cleared from the whole or part of the body.", "preferredTerm": "Drug Clearance", "submissionValue": "Drug Clearance", "synonyms": ["Clearance"]}, {"conceptId": "C199678", "definition": "The quantity of a drug in a unit volume or weight of another substance.", "preferredTerm": "Drug Concentration", "submissionValue": "Drug Concentration"}, {"conceptId": "C79370", "definition": "The branch of pharmacokinetics that studies the process by which a drug is distributed within the body.", "preferredTerm": "Pharmacokinetics: Distribution", "submissionValue": "Drug Distribution", "synonyms": ["Distribution", "FDA RPS Pharmacokinetics: Distribution"]}, {"conceptId": "C79372", "definition": "The branch of pharmacokinetics that studies the process by which a drug is eliminated from the body.", "preferredTerm": "Pharmacokinetics: Excretion", "submissionValue": "Drug Excretion", "synonyms": ["Excretion", "FDA RPS Pharmacokinetics: Excretion"]}, {"conceptId": "C79371", "definition": "The branch of pharmacokinetics that studies the process by which a drug is metabolized by the body.", "preferredTerm": "Pharmacokinetics: Metabolism", "submissionValue": "Drug Metabolism", "synonyms": ["FDA RPS Pharmacokinetics: Metabolism", "Metabolism"]}, {"conceptId": "C199690", "definition": "A measure of the potency of a compound, expressed as the concentration of the compound that induces a response halfway between the baseline and maximum.", "preferredTerm": "Half Maximal Effective Agent Concentration", "submissionValue": "Half Maximal Effective Concentration", "synonyms": ["50% Effective Concentration", "EC50", "Half-maximal Effective Concentration"]}, {"conceptId": "C191279", "definition": "The concentration of the inhibitory molecule that results in a 50% or greater reduction in infectivity, biological, or biochemical function.", "preferredTerm": "Fifty Percent Inhibitory Concentration", "submissionValue": "Half Maximal Inhibitory Concentration", "synonyms": ["50% Inhibitory Concentration", "Half-maximal Inhibitory Concentration", "IC50"]}, {"conceptId": "C199689", "definition": "The greatest effect that a compound can produce regardless of dose exposure or concentration.", "preferredTerm": "Maximal Effect", "submissionValue": "Maximal Effect", "synonyms": ["Emax", "Maximum Effect"]}, {"conceptId": "C70918", "definition": "The maximum concentration occurring at Tmax.", "preferredTerm": "Cmax", "submissionValue": "Maximum Concentration", "synonyms": ["Cmax", "Max Conc", "Maximum Concentration"]}, {"conceptId": "C85579", "definition": "The minimum concentration between dose time and dose time plus Tau (at Tmin).", "preferredTerm": "Cmin", "submissionValue": "Minimum Concentration", "synonyms": ["Cmin", "Min Conc", "Minimum Concentration"]}, {"conceptId": "C15720", "definition": "The study of the biochemical and physiological effects of a drug and its mechanisms of action, including the correlation of those effects and actions with its chemical structure.", "preferredTerm": "Pharmacodynamics", "submissionValue": "Pharmacodynamics", "synonyms": ["PD"]}, {"conceptId": "C20050", "definition": "The study of inherited variations in genes that determine and can be used to predict how an individual will respond to a drug or treatment.", "preferredTerm": "Pharmacogenomics", "submissionValue": "Pharmacogenomics", "synonyms": ["Pharmacogenetics"]}, {"conceptId": "C15299", "definition": "The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements. (NCI)", "preferredTerm": "Pharmacokinetics", "submissionValue": "Pharmacokinetics", "synonyms": ["Pharmacokinetics"]}, {"conceptId": "C70919", "definition": "The time of maximum observed concentration sampled during a dosing interval.", "preferredTerm": "Tmax", "submissionValue": "Time of Maximum Concentration", "synonyms": ["Time of CMAX", "Time of CMAX Observation"]}, {"conceptId": "C85825", "definition": "The time of minimum observed concentration sampled during a dosing interval.", "preferredTerm": "Tmin", "submissionValue": "Time of Minimum Concentration", "synonyms": ["Time of CMIN", "Time of CMIN Observation"]}, {"conceptId": "C102394", "definition": "Concentration at end of a dosing interval, immediately before the next dose is administered.", "preferredTerm": "Trough Concentration", "submissionValue": "Trough Concentration", "synonyms": ["Conc Trough", "Concentration Trough", "Ctrough", "Trough Level"]}]}